<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Pharmaceutical Market and Healthcare Services in Poland and Eastern Europe</title>
    <description>Pharma in Poland - Polish pharmaceutical market reports and newsletters, profiles of drug distributors and manufacturers. Free articles &amp; sector news, market data and databases.</description>
    <link>http://www.pharmapoland.com/</link>
    <lastBuildDate>Thu, 17 May 2012 08:02:15 +0200</lastBuildDate>
    <image>
      <url>http://www.polishmarket.com/_i/images/PMR.gif</url>
      <title></title>
      <link>http://www.pharmapoland.com/</link>
      <width>100</width>
      <height>51</height>
      <description>Pharma in Poland - Polish pharmaceutical market reports and newsletters, profiles of drug distributors and manufacturers. Free articles &amp; sector news, market data and databases.</description>
    </image>
    <item>
      <title>NFZ: spending on drug reimbursement exceeds PLN 2bn in January-March</title>
      <link>http://www.pharmapoland.com/121624/NFZ__spending_on_drug_reimbursement_exceeds_PLN_2bn_in_January_March.shtml</link>
      <description> In the first quarter of the year expenditures on drug reimbursement reached PLN 2.02bn (€482m), according to data published by the National Health Fund (NFZ). The figure represents&lt;/I&gt; ... </description>
      <pubDate>Wed, 09 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Arx Equity Partners to complete PE investment in healthcare sector in 2012</title>
      <link>http://www.pharmapoland.com/121615/Arx_Equity_Partners_to_complete_PE_investment_in_healthcare_sector_in_2012.shtml</link>
      <description> Arx Equity Partners, which owns Lexummedica, a network of ophthalmic clinics in Poland and the Czech Republic, has not managed to complete a private equity (PE) investment in the&lt;/I&gt; ... </description>
      <pubDate>Wed, 09 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Hungary to abolish solidarity fee paid by pharmacies?</title>
      <link>http://www.pharmapoland.com/121642/Hungary_to_abolish_solidarity_fee_paid_by_pharmacies_.shtml</link>
      <description> The “solidarity fee” paid by pharmacies in Hungary might be abolished, according to a recent draft bill published by the government modifying certain tax-related acts.&#13;
Currently,&lt;/I&gt; ... </description>
      <pubDate>Tue, 08 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Sales at Mediq down by 12% in Q1</title>
      <link>http://www.pharmapoland.com/121563/Sales_at_Mediq_down_by_12__in_Q1.shtml</link>
      <description> Mediq reported a 12% year-on-year decline in net sales at its Polish unit in the first quarter of 2012, to €120.9m, due to the hoarding effect in December 2011 and a depreciation&lt;/I&gt; ... </description>
      <pubDate>Tue, 08 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Sales at BioMaxima up by 2.2% in January-April</title>
      <link>http://www.pharmapoland.com/121530/Sales_at_BioMaxima_up_by_2_2__in_January_April.shtml</link>
      <description> BioMaxima, the listed supplier of in vitro diagnostics products, maintained a strong rate of growth in export sales and in new delivery contracts in April, while overall year-to-date&lt;/I&gt; ... </description>
      <pubDate>Tue, 08 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Sopharma’s Polish sales recover to nearly €3m in Q1</title>
      <link>http://www.pharmapoland.com/121514/Sopharma__8217_s_Polish_sales_recover_to_nearly___8364_3m_in_Q1.shtml</link>
      <description> Sopharma reported a more than ten-fold increase in Polish sales in the first quarter of the year, to €2.96m from €0.23m a year earlier, according to the group’s&lt;/I&gt; ... </description>
      <pubDate>Tue, 08 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Retail prices of 1,000 medicines to fall under new reimbursement list</title>
      <link>http://www.pharmapoland.com/121379/Retail_prices_of_1_000_medicines_to_fall_under_new_reimbursement_list.shtml</link>
      <description> The new version of the list of reimbursed medicines that took effect on 1 May reduces patient co-payment for 439 medicines and increases it for 667 items, by up to PLN 189.74 (€45.5)&lt;/I&gt; ... </description>
      <pubDate>Wed, 02 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Blirt disappointed with Q1 results</title>
      <link>http://www.pharmapoland.com/121375/Blirt_disappointed_with_Q1_results.shtml</link>
      <description> Sales and profits at BioLab Innovative Research Technologies (Blirt), a NewConnect-listed provider of R&amp;D services for pharma and biotech companies, came in below expectations in&lt;/I&gt; ... </description>
      <pubDate>Wed, 02 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Kalman Szell Plan 2.0. envisages further changes in Hungarian reimbursement system</title>
      <link>http://www.pharmapoland.com/121314/Kalman_Szell_Plan_2_0__envisages_further_changes_in_Hungarian_reimbursement_system.shtml</link>
      <description> The second version of the Kalman Szell Plan structural reform programme for 2013, announced by the Hungarian government on 23 April 2012, envisages the introduction of the “Spanish-model”&lt;/I&gt; ... </description>
      <pubDate>Tue, 01 May 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Internetowy Dom Zdrowia expects solid 2012 results</title>
      <link>http://www.pharmapoland.com/121276/Internetowy_Dom_Zdrowia_expects_solid_2012_results.shtml</link>
      <description> Internetowy Dom Zdrowia (IDZ, formerly Domzdrowia.pl) will in 2012 continue its move away from the image of an online pharmacy towards that of a comprehensive online retailer of&lt;/I&gt; ... </description>
      <pubDate>Mon, 30 Apr 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Bioton expects benefits from Watson-Actavis merger</title>
      <link>http://www.pharmapoland.com/121151/Bioton_expects_benefits_from_Watson_Actavis_merger.shtml</link>
      <description> The recently-announced takeover of Actavis by Watson Pharmaceuticals creates a huge opportunity for Bioton to accelerate export sales of its insulin products particularly on the&lt;/I&gt; ... </description>
      <pubDate>Fri, 27 Apr 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>BioMaxima reports 47% sales increase in Q1</title>
      <link>http://www.pharmapoland.com/121081/BioMaxima_reports_47__sales_increase_in_Q1.shtml</link>
      <description> Sales at BioMaxima, the listed supplier of in vitro diagnostics products, jumped by 46.5% year-on-year in the three months to March and amounted to nearly PLN 2.7bn (€0.64m),&lt;/I&gt; ... </description>
      <pubDate>Thu, 26 Apr 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Survey: pharma companies will not move clinical centres to Poland</title>
      <link>http://www.pharmapoland.com/121049/Survey__pharma_companies_will_not_move_clinical_centres_to_Poland.shtml</link>
      <description> According to a survey conducted by PMR Research for Pharma Poland News, Poland is not a place where pharmaceutical companies will move their clinical trial centres from other locations,&lt;/I&gt; ... </description>
      <pubDate>Wed, 25 Apr 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Gedeon Richter opens new biotechnology plant in Debrecen</title>
      <link>http://www.pharmapoland.com/120993/Gedeon_Richter_opens_new_biotechnology_plant_in_Debrecen.shtml</link>
      <description> The new biotechnology manufacturing plant of Gedeon Richter was opened on 19 April 2012. The investment cost about HUF 17bn (€50m) of which HUF 1.4bn (€4.6m) was provided&lt;/I&gt; ... </description>
      <pubDate>Tue, 24 Apr 2012 00:00:00 +0200</pubDate>
    </item>
    <item>
      <title>Medana to complete part of investment programme in 2012</title>
      <link>http://www.pharmapoland.com/120966/Medana_to_complete_part_of_investment_programme_in_2012.shtml</link>
      <description> As a result of an investment programme carried out by Medana Pharma, a division of the Polpharma group, at its facility in Sieradz (in the Lodzkie voivodship), in the Lodz Special Economic&lt;/I&gt; ... </description>
      <pubDate>Tue, 24 Apr 2012 00:00:00 +0200</pubDate>
    </item>
  </channel>
</rss>
<!--

		There was 4 queries

		
			CONNECT TO admin402@mysqls.polishmarket.serwery.pl;
			time: not available
			
			SET NAMES latin2;
			time: 0.00017118453979492
			
			USE baza402;
			time: not available
			
			SELECT id,	news_feature, title, content, date FROM arch_item WHERE news_feature = 1 AND dostepny = 1 AND new_category IN (37, 39, 40, 41, 68, 69) ORDER BY date DESC, id DESC LIMIT 15;
			time: 0.0010709762573242
			

		Total script time: 0.029305934906006-->

<!-- float(0.029344081878662)
 -->
